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Abstract
Background: A substantial proportion of children will experience at least one episode with bronchiolitis, and as
much as 2-3% of all children will be hospitalized with bronchiolitis during their first year of life. Bronchiolitis is
the most common reason for hospitalization of children in many countries, challenging both economy, area and
staffing in paediatric departments. Objective: To determine outcome (in terms of clinical severity score and
hospital stay) of N-acetylcysteine nebulization versus salbutamol nebulization in children with acute
bronchiolitis. Material and Methods: The study cases were randomly divided into 2 groups by draws methods.
Group A, each child was nebulized with 20 mg NAC in 3 ml of 0.9% of saline while group B was nebulized with
2.5 mg salbutamol in 3 ml of 0.9% saline solution. Patients of each group were nebulized three times a day (8
hours apart) for 5 days. These patients were closely monitored for the severity of the disease daily and clinical
severity score was employed to record any improvement in both cases. All the data was entered and analyzed
using SPSS-18. Results: Of these 390 study cases, 228 (58.5%) were boys while 162 (41.5%) were girls. Mean
age of our study cases was 7.92 ± 5.18 months . Most of the study cases i.e. 264 (67.7%) were from poor social
background and mothers of most of these children were less educated as 85.6% of the mothers of these children
were having their educational status equal/less than matriculation. Mean hospital stay in our study was 4.73 ±
0.829 days. Mean baseline clinical severity score was 5.52 ± 813. Mean clinical severity score after therapy was
1.85 ± 0.812 (with minimum clinical severity score was 1 while maximum was score was 4). Clinical severity
score in group A was 1.21 ± 0.405 while in group B was 2.49 ± 0.578 (p= 0.000). Conclusion: Our study results
support the use N – acetylcysteine nebulization in children with acute bronchiolitis as compared with salbutamol
nebulization. N – acetylcysteine nebulization was found to be more effective in improving clinical severity score
and reducing duration of hospitalization. Its use was safe, reliable and no adverse side effects were noted.
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Introduction:
Bronchiolitis is an acute inflammatory obstruction of small airways (bronchioles and alveoli) in children that
occurs in first two years of life 1. It is characterized by fever, rhinitis, cough, tachypnea, expiratory wheeze and
increased respiratory effort. Acute viral bronchiolitis is one of the most common causes of hospitalization during
infancy with respiratory syncytial virus (RSV) being the major causative agent (85%) 2-4.
Globally, among healthy, full term infants, 80% of hospitalizations occur in the first year of life and 50% of
hospitalizations occur in children 1-3 months of age. In Pakistan, acute respiratory illness (ARI) is the leading
cause of death in young children responsible for 20-30% of all child death under age 5 years. It occurs in a
seasonal pattern, with peak incidence in the winter to spring months. Risk factors for early onset disease and
subsequent hospitalization include low birth weight, prematurity, lower socioeconomic group, crowded living
conditions, parental smoking, absence of breast-feeding, and day care centers. Majority of the children present
with respiratory distress and wheezing5-7. Pathophysiologically bronchiolitis is an infection of the bronchiolar
epithelium with subsequent profound submucosal and advential oedema, increased secretion of mucus,
peribronchiolar mononuclear infiltration and epithelial cell necrosis 8-10. These changes obstruct flow in the small
airways leading to hyperinflation, atelectasis and wheezing8. N-acetylcysteine (NAC) is an antioxidant that
cleaves disulphide bonds by converting them to 2 sulphuryl groups 11. This action results in the breakup of
mucoproteins in lung mucus, reducing chain lengths and thinning mucus, mucolytics like NAC has been studies
in the treatment of various diseases states such as pulmonary in nature ( cystic fibrosis, chronic bronchitis,
idiopathic pulmonary fibrosis and critically ill states)9,12-15.
A study has reported significant decrease in clinical severity score by using NAC nebulization versus
salbutamol i.e. it was decreased from 5.38 ± 2.62 to 0.88 ± 1.08 with NAC and from 4.68 ± 2.2 to 1.90 ± 1.32
after completion the course of therapy for 5 days6. Similarly mean duration for hospitalization was also short
with NAC nebulization i.e. 4.36 ± 1.66 days versus 4.98 ± 2.6 days in case of salbutamol nebulization6.
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This study was done to determine outcome of NAC compared with those of salbutamol in the patients of
acute bronchiolitis as there is very much limited data available of this topic.
Patients and Methods:
Three hundred and ninety hospitalized children with acute bronchiolitis were registered in this randomized
controlled trial from Department of Pediatrics, Bakhtawar Amin Hospital Multan. Patients with underlying
broncho-pulmonary dysplasia, chronic lung diseases, neuromuscular impairment, immunodeficiency or
congenital heart disease, patients with previous history of malignancy and those already taking NAC or
salbutamol therapy were excluded from our study. Informed consent was taken from the parents of each child,
baseline information like heart rate, respiratory rate, wheeze score and clinical severity score were taken. Acute
Bronchiolitis was defined as Children having clinical severity score more than 4 with fever (more than 101 F0)
and cough within 2 days. These study cases were randomly divided into 2 groups by draws methods (Group A
and Group B with 190 patients in each group). Group A, each child was nebulized with 20 mg NAC in 3 ml of
0.9% of saline while group B was nebulized with 2.5 mg salbutamol in 3 ml of 0.9% saline solution. Patients of
each group were nebulized three times a day (8 hours apart) for 5 days. These patients were closely monitored
for the severity of the disease daily and clinical severity score was employed to record any improvement in both
cases. Final outcome was measured at day five. All the data was entered and analyzed using SPSS-18.
Descriptive statistics was applied to calculate mean and standard deviation for age of patients, clinical severity
score and duration of hospital stays. Frequencies and percentage was tabulated for the categorical variables like
gender and age groups. Student’s t test was applied to compare clinical severity and hospital stay in both groups.
Results:
Our study included a total 390 children with acute bronchiolitis who met inclusion criteria of our study. Of these
390 study cases, 228 (58.5%) were boys while 162 (41.5%) were girls. Mean age of our study cases was 7.92 ±
5.18 months ranging from 2 months to 24 months. Mean age of our study cases in group A was 8.07 ± 5.46
months while that of group B was 7.77 ± 4.91 months (p = 0.579) while 318 (81.5%) were aged less than 12
months. Most of the study cases i.e. 264 (67.7%) were from poor social background and mothers of most of
these children were less educated as 85.6% of the mothers of these children were having their educational status
equal/less than matriculation. Mean hospital stay in our study was 4.73 ± 0.829 days ranging from 3 days to 7
days). Mean baseline clinical severity score was 5.52 ± 813 (with minimum baseline clinical severity score was 5
and maximum was 8). Mean clinical severity score after therapy was 1.85 ± 0.812 (with minimum clinical
severity score was 1 while maximum was score was 4). Clinical severity score in group A was 1.21 ± 0.405
while in group B was 2.49 ± 0.578 (p= 0.000).
Table No. 1
Distribution of clinical severity score after therapy in both groups.
Groups
Clinical severity score
P value
Mean SD
Group A 1.21 0.405
0.000
Group B 2.49 0.578
Table No. 2
Distribution of hospital stay in both groups.
(n=390)
Groups
Hospital stay
P value
Mean SD
Group A 4.53 0.706
0.000
Group B 4.93 0.894
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Table No. 3
Stratification of clinical severity score with regards to gender.
(n=390)
Gender Groups
Clinical Severity Score
P valueMean SD
Male
(n=228)
Group A
(n=110)
1.22 0.415
0.000
Group B
(n=118)
2.54 0.500
Female
(n=162)
Group A
(n=85)
1.19 0.393
0.000
Group B
(n=77)
2.40 0.674
Table No. 4
Stratification of Clinical severity score with regards to age.
(n=390)
Age Groups
Clinical Severity Score
P valueMean SD
Less than
12 months
(n=318)
Group A
(n=155)
1.21 0.406
0.000
Group B
(n=163)
2.48 0.592
12 – 24
months
(n=72)
Group A
(n=40)
1.20 0.405
0.000
Group B
(n=32)
2.50 0.508
Discussion:
Our study included a total 390 children with acute bronchiolitis who met inclusion criteria of our study. Of these
390 study cases, 228 (58.5%) were boys while 162 (41.5%) were girls. Different studies have documented male
gender predominance in patients with acute bronchiolitis. A study conducted by Arif et al 16 from Lahore
reported 68 % boys with acute bronchiolitis which is similar to our study results. Another study from Faisalabad
by Ahmed et al 17 reported 1.4:1 male to female ratio which is showing male gender predominance. Jacobs et al
18 reported 69 % boys with acute bronchiolitis showing male gender predominance. However Naz et al 6 from
Lahore reported 40 % boys with acute bronchiolitis and 60 % girls which is quite different from our study results.
Mean age of our study cases was 7.92 ± 5.18 months ranging from 2 months to 24 months. Mean age of our
study cases in group A was 8.07 ± 5.46 months while that of group B was 7.77 ± 4.91 months (p = 0.579). Our
study results have indicated that majority of our study cases i.e. 318 (81.5%) were aged less than 12 months. Airf
et al 16 from Lahore reported 5.43 ± 9.44 months mean age of the children with acute bronchiolitis which is close
to our study results. Ahmed et al 17 from Faisalabad reported 7.6 ± 4.7 months mean age which is close to our
study results. Jacobs et al 18 reported 6.0 ± 3.9 months mean age, similar to our results. Naz et al 6 reported 3
months mean age which is a bit lower than that of our study results. Most of the study cases i.e. 264 (67.7%)
were from poor social background and mothers of most of these children were less educated as 85.6% of the
mothers of these children were having their educational status equal/less than matriculation. Similar findings
have been reported by Ahmed et al 17 from Faisalabad. Mean hospital stay in our study was 4.73 ± 0.829 days
(with minimum hospital stay was 3 days while maximum hospital stay was 7 days). Flores et al 19 reported 5.4 ±
2.1 days hospital stay with acute bronchiolitis which is close to our study findings. Naz et al 6 reported 4.67 ± 2.2
days mean duration of hospitalization which is same as that of our study results. Mean baseline clinical severity
score was 5.52 ± 813 (with minimum baseline clinical severity score was 5 and maximum was 8). A study
conducted in Lahore by Ejaz et al 20 reported 5.68 ± 0.73 clinical severity score which is in compliance with our
study results. Jacobs et al 18 reported 5.7 ± 1.8 mean score which is similar to that of our study results. Mean
clinical severity score after therapy was 1.85 ± 0.812 (with minimum clinical severity score was 1 while
maximum was score was 4). Clinical severity score in group A was 1.21 ± 0.405 while in group B was 2.49 ±
0.578 (p= 0.000). Naz et al 6 also reported similar results as mean score in group A (treated with N –
acetylcystein) was 0.88 ± 1.08 while in group B treated with salbutamol was 1.90 ± 1.32. These results are same
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as that of our findings showing N – acetylcystein to be more effective.
Conclusion:
Our study results support the use N – acetylcysteine nebulization in children with acute bronchiolitis as
compared with salbutamol nebulization. N – acetylcysteine nebulization was found to be more effective in
improving clinical severity score and reducing duration of hospitalization significantly. Its use was safe, reliable
and no adverse side effects were noted.
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